A Study to Evaluate the add-on Efficacy and Safety of Opicapone 50 mg or an Extra Dose of L-DOPA 100 mg for the Treatment of Wearing-off in Patients With PD

NCT04821687 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

169

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: Ongentys 50mg
DRUG: Madopar Tab. 125 or Perkin Tab. 25-100mg

Sponsor

SK Chemicals Co., Ltd.